Sotera Health Co【SHC】

時価総額

$54.5億

PER

医療向け滅菌と試験・助言サービスの最大手。ガンマ/EO/Eビームなどの滅菌と微生物・分析検査を展開。ワーバーグ・ピンカスとGTCRが約43.4%出資、2020年11月にIPO。米国中心に50カ国超で展開。

	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Service	806	865	906	942
Product	126	139	144	159
Total net revenues	931	1,004	1,049	1,100
Service	357	391	419	440
Product	56	56	54	59
Cost of Revenue	413	447	472	498
Gross profit	519	557	577	602
Selling, General and Administrative Expense	198	246	237	243
Amortization of intangible assets	64	63	64	62
Total operating expenses	262	309	300	305
Operating income	257	248	277	298
Interest expense, net	-74	-80	-143	-165
Loss on refinancing of debt	-	-	-	-24
Impairment of investment in unconsolidated affiliate	-	10	-	-
Foreign exchange loss	-1	-0	-0	-0
Other income, net	15	6	7	5
Income (loss) before income taxes	176	-243	106	114
Income Tax Expense (Benefit)	59	-10	55	69
Net income (loss)	117	-234	51	44
Pension and post-retirement benefits (net of taxes of $2,804, $(3,420) and $7,022, respectively)	-27	-21	11	-8
Interest rate derivatives (net of taxes of $(1,856), $(5,467) and $7,387, respectively)	0	21	-16	-5
Foreign currency translation	-16	-65	40	-119
Comprehensive income (loss)	127	-257	65	-71
Earnings Per Share, Basic	0.41	-0.83	0.18	0.16
Earnings Per Share, Diluted	0.41	-0.83	0.18	0.16